INmune Bio, Inc. (INMB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

INmune Bio, Inc. (INMB) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

INMB Income Statement

INmune Bio, Inc. (INMB) annual income statement — 11-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	50K	0	0	0	14K	28K	43K	46K	38K	97K	98K	16K	163K	163K
Revenue Growth %	-	-	-100%	-	-	-	257.14%	-100%	-100%	-100%	-63.16%	-71.13%	-56.12%	187.5%	-76.69%	-40.49%	600%	-	3975%	1381.82%
Cost of Goods Sold	0	0	52K	56K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-52K	-56K	0	0	50K	0	0	0	14K	28K	43K	46K	38K	97K	98K	16K	163K	163K
Gross Margin %	-	-	-	-	-	-	100%	-	-	-	100%	100%	100%	100%	100%	100%	100%	100%	100%	100%
Gross Profit Growth %	-	-	-204%	-	-	-	257.14%	-100%	-100%	-100%	-63.16%	-71.13%	-56.12%	187.5%	-76.69%	-40.49%	600%	-	3975%	1381.82%
Operating Expenses	5.01M	1.48M	5.76M	5.42M	7.43M	24.57M	9.96M	9.47M	12.29M	9.87M	11.03M	8.41M	8.57M	6.46M	6.46M	5.74M	7.54M	6.4M	6.64M	9.19M
OpEx % of Revenue	-	-	-	-	-	-	19910%	-	-	-	78792.86%	30025%	19932.56%	14036.96%	17002.63%	5916.49%	7694.9%	40025%	4074.23%	5639.88%
Selling, General & Admin	1.85M	2.28M	2.17M	3.15M	2.68M	2.25M	2.32M	1.99M	2.26M	2.81M	2.34M	2.4M	2.59M	2.31M	2.33M	2.33M	2.38M	2.21M	2.33M	2.13M
SG&A % of Revenue	-	-	-	-	-	-	4632%	-	-	-	16700%	8571.43%	6013.95%	5019.57%	6126.32%	2401.03%	2430.61%	13843.75%	1430.67%	1303.68%
Research & Development	3.16M	803K	3.64M	2.33M	4.89M	5.8M	7.64M	7.35M	10.07M	7.05M	8.69M	6.01M	5.99M	4.15M	4.13M	3.41M	5.16M	4.19M	4.31M	7.07M
R&D % of Revenue	-	-	-	-	-	-	15278%	-	-	-	62092.86%	21453.57%	13918.6%	9017.39%	10876.32%	3515.46%	5264.29%	26181.25%	2643.56%	4336.2%
Other Operating Expenses	0	-1000K	-52K	-56K	-134K	1000K	0	120K	-40K	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-5.01M	-1.48M	-5.81M	-5.47M	-7.43M	-24.57M	-9.9M	-9.47M	-12.29M	-9.87M	-11.02M	-8.38M	-8.53M	-6.41M	-6.42M	-5.64M	-7.44M	-6.39M	-6.48M	-9.03M
Operating Margin %	-	-	-	-	-	-	-19810%	-	-	-	-78692.86%	-29925%	-19832.56%	-13936.96%	-16902.63%	-5816.49%	-7594.9%	-39925%	-3974.23%	-5539.88%
Operating Income Growth %	32.61%	93.99%	41.32%	42.18%	39.5%	-149.07%	10.09%	-12.98%	-44.07%	-53.88%	-71.52%	-48.51%	-14.58%	-0.36%	0.85%	37.52%	17.49%	2.53%	-42.44%	-181.4%
EBITDA	-5.01M	-1.41M	-5.76M	-5.42M	-6.47M	-8.06M	-9.74M	-9.22M	-12.27M	-9.84M	-10.98M	-8.38M	0	0	0	0	0	0	0	0
EBITDA Margin %	-	-	-	-	-	-	-19478%	-	-	-	-78450%	-29925%	-	-	-	-	-	-	-	-
EBITDA Growth %	22.61%	82.5%	40.86%	41.22%	47.26%	18.13%	11.33%	-10.01%	-	-	-	-	-	-	-	-	100%	100%	-	-
D&A (Non-Cash Add-back)	0	66K	52K	56K	0	0	0	0	15K	24K	34K	0	8.53M	6.41M	6.42M	5.64M	7.44M	6.39M	6.48M	9.03M
EBIT	0	-1.27M	-5.41M	-5.26M	-6.47M	-8.06M	-9.74M	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.53M	-6.41M	-6.42M	-5.64M	-7.44M	-6.39M	-6.48M	-9.03M
Net Interest Income	0	0	0	210K	0	0	0	0	0	0	0	0	0	631K	499K	1.23M	243K	-450K	-425K	-21.31M
Interest Income	0	0	0	210K	0	0	0	0	0	0	0	0	0	631K	612K	1.42M	525K	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	113K	191K	282K	450K	425K	21.31M
Other Income/Expense	287K	203K	405K	210K	961K	113K	166K	249K	193K	119K	-8K	-29K	-35K	-90K	-113K	-191K	-282K	-450K	-425K	-641K
Pretax Income	-4.72M	-1.27M	-5.41M	-5.26M	-6.47M	-24.46M	-9.74M	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.56M	-6.5M	-6.54M	-5.83M	-7.72M	-6.84M	-6.9M	-9.67M
Pretax Margin %	-	-	-	-	-	-	-19478%	-	-	-	-78750%	-30028.57%	-19913.95%	-14132.61%	-17200%	-6013.4%	-7882.65%	-42737.5%	-4234.97%	-5933.13%
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-4.72M	-1.27M	-5.41M	-5.26M	-6.47M	-24.46M	-9.74M	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.56M	-6.5M	-6.54M	-5.83M	-7.72M	-6.84M	-6.9M	-9.67M
Net Margin %	-	-	-	-	-	-	-19478%	-	-	-	-78750%	-30028.57%	-19913.95%	-14132.61%	-17200%	-6013.4%	-7882.65%	-42737.5%	-4234.97%	-5933.13%
Net Income Growth %	27.04%	94.8%	44.48%	42.89%	46.48%	-150.95%	11.66%	-9.63%	-41.22%	-49.92%	-68.68%	-44.15%	-10.85%	4.93%	5.32%	39.69%	18.32%	-2.75%	-51.51%	-201.84%
Net Income (Continuing)	-4.72M	-1.27M	-5.41M	-5.26M	-6.47M	-24.46M	-9.74M	-9.22M	-12.09M	-9.75M	-11.03M	-8.41M	-8.56M	-6.5M	-6.54M	-5.83M	-7.72M	-6.84M	-6.9M	-9.67M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.17	-0.05	-0.20	-0.20	-0.24	-1.05	-0.43	-0.41	-0.60	-0.50	-0.61	-0.47	-0.48	-0.36	-0.37	-0.34	-0.45	-0.41	-0.41	-0.56
EPS Growth %	29.17%	95.24%	53.49%	51.22%	60%	-110%	29.51%	12.77%	-25%	-38.89%	-64.86%	-38.24%	-6.67%	12.2%	9.76%	39.29%	18.18%	6.82%	-28.13%	-124%
EPS (Basic)	-0.17	-0.05	-0.20	-0.20	-0.24	-1.05	-0.43	-0.41	-0.60	-0.50	-0.61	-0.47	-0.48	-0.36	-0.37	-0.34	-0.45	-0.41	-0.41	-0.56
Diluted Shares Outstanding	27.81M	26.72M	26.59M	26.59M	26.59M	23.3M	22.5M	22.28M	20.19M	19.31M	18.03M	17.95M	18.01M	17.95M	17.95M	17.93M	17.95M	17.95M	17.87M	17.33M
Basic Shares Outstanding	27.81M	26.72M	26.59M	26.59M	26.59M	23.3M	22.5M	22.28M	20.19M	19.31M	18.03M	17.95M	18.01M	17.95M	17.95M	17.93M	17.95M	17.95M	17.87M	17.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-